Does Semaglutide Cause Acid Reflux?
Semaglutide, the active ingredient in drugs like Ozempic and Wegovy, can cause gastrointestinal side effects including acid reflux (also called gastroesophageal reflux disease or GERD). Clinical trials and post-marketing reports list dyspepsia, heartburn, and reflux as common issues, affecting 5-10% of users. These stem from the drug's action as a GLP-1 receptor agonist, which slows gastric emptying and relaxes the lower esophageal sphincter, allowing stomach acid to back up.[1][2]
How Common Is Acid Reflux with Semaglutide?
In pivotal trials for Ozempic (for diabetes), upper abdominal pain and dyspepsia occurred in up to 9% of patients, with reflux symptoms noted in real-world data at similar rates. Wegovy trials for weight loss reported GERD in 4-5% of users, often dose-dependent—higher doses (2.4 mg weekly) increase risk. Nausea, a more frequent side effect (up to 44%), can worsen reflux by irritating the esophagus.[3][4]
Why Does Semaglutide Trigger Reflux?
It delays stomach emptying by 20-38%, raising pressure in the stomach and promoting acid leakage into the esophagus. This mimics overeating effects, even on normal meals. Patients with pre-existing GERD see symptoms amplify, per FDA labels.[2][5]
What Do Patients Report About Acid Reflux?
User forums and adverse event databases like FDA's FAERS show thousands of reflux complaints, often starting in the first weeks and easing over time for many. Some describe burning chest pain or regurgitation, distinct from heart issues—doctors advise antacids or PPIs like omeprazole for relief.[6]
How to Manage Acid Reflux on Semaglutide?
Start low-dose and titrate slowly to minimize GI upset. Lifestyle fixes include smaller meals, avoiding triggers like spicy food or lying down post-eating, and elevating the bed head. Over-the-counter antacids help most; persistent cases may need H2 blockers or PPIs. Consult a doctor before combining, as interactions exist.[1][7]
When Should You Worry About Reflux Symptoms?
Mild heartburn is expected, but seek care for severe pain, vomiting blood, weight loss beyond expected, or swallowing issues—these could signal esophagitis or rare complications like gastroparesis. Semaglutide carries a boxed warning for thyroid tumors, unrelated to reflux.[2][4]
Does It Go Away, and Who Is at Higher Risk?
Symptoms peak early (first 4-8 weeks) and resolve in 70-80% of users as tolerance builds. Higher risk for those over 65, with obesity, or prior GI conditions. Switching to oral semaglutide (Rybelsus) may reduce reflux due to faster absorption, but data is limited.[3][8]
[1]: FDA Ozempic Label
[2]: FDA Wegovy Label
[3]: NEJM, STEP 1 Trial (2021)
[4]: Novo Nordisk Safety Data
[5]: Gastroenterology Review on GLP-1s (2022)
[6]: FDA FAERS Database
[7]: Mayo Clinic Semaglutide Guidance
[8]: Diabetes Care Journal (2023)